Leonard Braden Michael
CIK 1373603
Transactions on file
34
Open-market buys
18
Win rate (buys)
100%
2 scored
Avg % since filing (buys)
+10.4%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-05 | 2026-10-02 | OM Outset Medical, Inc. | Buy | 16,575 | $64.2K | +5.3% | open → | |
| 2026-10-05 | 2026-10-01 | OM Outset Medical, Inc. | Buy | 228,334 | $806.0K | +15.6% | open → | |
| 2026-05-18 | 2026-05-15 | OM Outset Medical, Inc. | X | 323,000 | $1.61M | -18.4% | open → | |
| 2026-05-12 | 2026-05-11 | OM Outset Medical, Inc. | X | 96,900 | $484.5K | -18.4% | open → | |
| 2026-05-12 | 2026-05-08 | OM Outset Medical, Inc. | X | 197,600 | $988.0K | -18.4% | open → | |
| 2026-04-27 | 2026-04-23 | ACRS Aclaris Therapeutics, Inc. | Sale | 300,000 | $1.36M | +32.9% | open → | |
| 2025-02-28 | 2025-02-28 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 85,068 | $391.3K | — | open → |
| 2025-02-28 | 2025-02-27 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 86,802 | $387.1K | — | open → |
| 2025-02-28 | 2025-02-26 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 164,886 | $661.2K | — | open → |
| 2025-03-20 | 2025-03-19 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 25,000 | $123.5K | — | open → |
| 2025-03-20 | 2025-03-18 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 44,341 | $209.7K | — | open → |
| 2025-03-20 | 2025-03-18 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 18,000 | $82.8K | — | open → |
| 2025-03-20 | 2025-03-20 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 30,600 | $171.7K | — | open → |
| 2025-03-27 | 2025-03-26 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 20,407 | $102.9K | — | open → |
| 2025-03-27 | 2025-03-27 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 16,593 | $86.1K | — | open → |
| 2025-04-02 | 2025-04-02 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 15,209 | $61.4K | — | open → |
| 2025-04-02 | 2025-03-31 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 19,566 | $85.7K | — | open → |
| 2025-04-24 | 2025-04-23 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 50,000 | $149.0K | — | open → |
| 2025-04-24 | 2025-04-22 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 300,000 | $900.0K | — | open → |
| 2025-04-28 | 2025-03-26 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 20,407 | $102.9K | — | open → |
| 2025-04-28 | 2025-03-27 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 16,593 | $86.1K | — | open → |
| 2025-04-28 | 2025-03-27 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 16,593 | $86.1K | — | open → |
| 2025-04-28 | 2025-03-26 | ADVM Adverum Biotechnologies, Inc. | 10% | Buy | 20,407 | $102.9K | — | open → |
| 2025-05-30 | 2025-05-30 | ANTX AN2 Therapeutics, Inc. | 10% | Sale | 425,000 | $429.3K | +259.4% | open → |
| 2025-05-30 | 2025-05-28 | ANTX AN2 Therapeutics, Inc. | 10% | Sale | 2,000,000 | $2.32M | +212.9% | open → |
| 2025-05-30 | 2025-05-30 | ANTX AN2 Therapeutics, Inc. | 10% | Sale | 7,000 | $7.2K | +252.4% | open → |
| 2025-05-30 | 2025-05-28 | ANTX AN2 Therapeutics, Inc. | 10% | Sale | 100,000 | $116.0K | +212.9% | open → |
| 2025-06-16 | 2025-05-28 | ANTX AN2 Therapeutics, Inc. | 10% | Sale | 200,000 | $218.0K | +233.0% | open → |
| 2025-12-05 | 2025-12-04 | ADVM Adverum Biotechnologies, Inc. | Sale | 524,560 | $2.20M | — | open → | |
| 2025-12-03 | 2025-12-03 | ADVM Adverum Biotechnologies, Inc. | Sale | 222,925 | $929.6K | — | open → | |
| 2025-12-03 | 2025-12-02 | ADVM Adverum Biotechnologies, Inc. | Sale | 51,961 | $218.2K | — | open → | |
| 2025-12-03 | 2025-12-01 | ADVM Adverum Biotechnologies, Inc. | Sale | 300,000 | $1.26M | — | open → | |
| 2025-10-07 | 2025-10-03 | ASTC ASTROTECH Corp | Sale | 9,166 | $53.4K | -14.1% | open → | |
| 2025-10-07 | 2025-10-03 | ASTC ASTROTECH Corp | Sale | 220,410 | $1.57M | -29.7% | open → |
